Radiolabelled peptides in diagnosis and therapy: an introduction
- PMID: 22388632
- DOI: 10.1007/s00259-012-2064-5
Radiolabelled peptides in diagnosis and therapy: an introduction
Similar articles
-
Rationale for the use of radiolabelled peptides in diagnosis and therapy.Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S4-10. doi: 10.1007/s00259-011-2038-z. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388630 Review.
-
Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.Q J Nucl Med. 2003 Dec;47(4):223-37. Q J Nucl Med. 2003. PMID: 14973415 Review.
-
Peptide radiopharmaceuticals for diagnosis and therapy.Eur J Nucl Med. 2001 Oct;28(10):1555-65. doi: 10.1007/s002590100583. Epub 2001 Jul 31. Eur J Nucl Med. 2001. PMID: 11685500 Review.
-
Peptide radiopharmaceuticals in diagnosis and therapy of cancer and inflammation/infection. Proceedings of the 16th IRIST (International Research Group on Immunoscintigraphy and Therapy) Congress. May 8-10, 2003.Cancer Biother Radiopharm. 2004 Feb;19(1):55-134. doi: 10.1089/108497804773391676. Cancer Biother Radiopharm. 2004. PMID: 15068611 No abstract available.
-
Radiolabelled peptides--promises and pitfalls.Nucl Med Commun. 2000 Jun;21(6):507-9. doi: 10.1097/00006231-200006000-00001. Nucl Med Commun. 2000. PMID: 10894558 No abstract available.
Cited by
-
Surgical palliation in poorly differentiated neuroendocrine carcinoma of the hypopharynx: Case report.Cancer Rep (Hoboken). 2022 Aug;5(8):e1558. doi: 10.1002/cnr2.1558. Epub 2021 Oct 5. Cancer Rep (Hoboken). 2022. PMID: 34609069 Free PMC article.
-
EJNMMI: the European way of communicating science.Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):1-3. doi: 10.1007/s00259-012-2301-y. Eur J Nucl Med Mol Imaging. 2013. PMID: 23149822 No abstract available.
-
Evaluation of 99m Tc-MccJ25 peptide analog in mice bearing B16F10 melanoma tumor as a diagnostic radiotracer.Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):172-180. doi: 10.22038/AOJNMB.2019.37712.1251. Asia Ocean J Nucl Med Biol. 2019. PMID: 31380457 Free PMC article.
-
Prospective of ⁶⁸Ga-radiopharmaceutical development.Theranostics. 2013 Dec 10;4(1):47-80. doi: 10.7150/thno.7447. Theranostics. 2013. PMID: 24396515 Free PMC article. Review.
-
Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.Mol Imaging Biol. 2018 Oct;20(5):798-807. doi: 10.1007/s11307-018-1176-0. Mol Imaging Biol. 2018. PMID: 29464496
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources